Shares of Emerald Health Therapeutics, Inc. (CVE:EMH – Get Free Report) were down 3.8% during mid-day trading on Wednesday . The stock traded as low as C$0.25 and last traded at C$0.26. Approximately 384,329 shares traded hands during mid-day trading, a decline of 40% from the average daily volume of 644,760 shares. The stock had previously closed at C$0.27.
Emerald Health Therapeutics Stock Down 3.8 %
The stock has a 50-day moving average of C$0.26 and a 200 day moving average of C$0.26. The company has a market capitalization of C$52.28 million and a PE ratio of -0.37. The company has a quick ratio of 2.61, a current ratio of 2.97 and a debt-to-equity ratio of 35.45.
Emerald Health Therapeutics Company Profile
Emerald Health Therapeutics, Inc, together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc and changed its name to Emerald Health Therapeutics, Inc in June 2015.
Featured Articles
- Five stocks we like better than Emerald Health Therapeutics
- Buy P&G Now, Before It Sets A New All-Time High
- Nebius Group: NVIDIA’s Investment Sparks All-Time Highs
- Are Penny Stocks a Good Fit for Your Portfolio?
- SoFi Stock Rallying Strong in the Last 5 Days—What’s Driving It?
- Business Services Stocks Investing
- Intel Surges on M&A Talks: Rally Beginning or Just a Headfake?
Receive News & Ratings for Emerald Health Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Emerald Health Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
